CN117904162A - Method for improving erythromycin yield by modifying rhodosporidium saccharatum SACE_5680 gene and application - Google Patents
Method for improving erythromycin yield by modifying rhodosporidium saccharatum SACE_5680 gene and application Download PDFInfo
- Publication number
- CN117904162A CN117904162A CN202410109259.3A CN202410109259A CN117904162A CN 117904162 A CN117904162 A CN 117904162A CN 202410109259 A CN202410109259 A CN 202410109259A CN 117904162 A CN117904162 A CN 117904162A
- Authority
- CN
- China
- Prior art keywords
- erythromycin
- sace
- gene
- rhodosporidium
- yield
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title claims abstract description 123
- 229960003276 erythromycin Drugs 0.000 title claims abstract description 66
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 56
- 241000223252 Rhodotorula Species 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 19
- 241000187560 Saccharopolyspora Species 0.000 claims abstract description 16
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 14
- 238000010353 genetic engineering Methods 0.000 claims abstract description 8
- 239000002773 nucleotide Substances 0.000 claims abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 4
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 241000209051 Saccharum Species 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 238000000855 fermentation Methods 0.000 abstract description 11
- 230000004151 fermentation Effects 0.000 abstract description 11
- 210000000349 chromosome Anatomy 0.000 abstract description 6
- 241001334574 Erythromyces Species 0.000 abstract description 4
- 238000009776 industrial production Methods 0.000 abstract description 2
- 229930006677 Erythromycin A Natural products 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 11
- XZNUGFQTQHRASN-XQENGBIVSA-N apramycin Chemical group O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O XZNUGFQTQHRASN-XQENGBIVSA-N 0.000 description 9
- 229950006334 apramycin Drugs 0.000 description 9
- 238000012217 deletion Methods 0.000 description 9
- 230000037430 deletion Effects 0.000 description 9
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 238000012258 culturing Methods 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 108091008053 gene clusters Proteins 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 238000010276 construction Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000001938 protoplast Anatomy 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- DZCOSWPAQGXWKC-TZIZHKBZSA-N (3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3-(hydroxymethyl)-5,7,9,11,13-pentamethyl-oxacyclotetradecane Chemical compound O([C@@H]1[C@@H](CO)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 DZCOSWPAQGXWKC-TZIZHKBZSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- IDRYSCOQVVUBIJ-UHFFFAOYSA-N Erythromycin-B Natural products CC1C(OC2C(C(CC(C)O2)N(C)C)O)C(C)(O)CC(C)C(=O)C(C)C(O)C(C)C(CC)OC(=O)C(C)C1OC1CC(C)(OC)C(O)C(C)O1 IDRYSCOQVVUBIJ-UHFFFAOYSA-N 0.000 description 2
- MWFRKHPRXPSWNT-UHFFFAOYSA-N Erythromycin-C Natural products CC1C(OC2C(C(CC(C)O2)N(C)C)O)C(C)(O)CC(C)C(=O)C(C)C(O)C(O)(C)C(CC)OC(=O)C(C)C1OC1CC(C)(O)C(O)C(C)O1 MWFRKHPRXPSWNT-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 108700005075 Regulator Genes Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- -1 cold stock Proteins 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- IDRYSCOQVVUBIJ-PPGFLMPOSA-N erythromycin B Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@H]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)C)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 IDRYSCOQVVUBIJ-PPGFLMPOSA-N 0.000 description 2
- CLQUUOKNEOQBSW-KEGKUKQHSA-N erythromycin D Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@H]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)C)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 CLQUUOKNEOQBSW-KEGKUKQHSA-N 0.000 description 2
- PRUSTPADOGZAML-UHFFFAOYSA-N erythromycin E Natural products O1C2C(C)C(OC3C(C(CC(C)O3)N(C)C)O)C(C)(O)CC(C)C(=O)C(C)C(O)C(O)(C)C(CC)OC(=O)C2COC21CC(C)(OC)C(O)C(C)O2 PRUSTPADOGZAML-UHFFFAOYSA-N 0.000 description 2
- PRUSTPADOGZAML-LMXGZOGMSA-N erythromycin E Chemical compound C([C@H]1C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@@H](C)[C@@H]1O1)(C)O)CC)O[C@]21C[C@@](C)(OC)[C@@H](O)[C@H](C)O2 PRUSTPADOGZAML-LMXGZOGMSA-N 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000012224 gene deletion Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000006384 oligomerization reaction Methods 0.000 description 2
- 230000024053 secondary metabolic process Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 description 1
- 101100002068 Bacillus subtilis (strain 168) araR gene Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 101100445522 Saccharopolyspora erythraea (strain ATCC 11635 / DSM 40517 / JCM 4748 / NBRC 13426 / NCIMB 8594 / NRRL 2338) ermE gene Proteins 0.000 description 1
- 101100226000 Saccharopolyspora erythraea (strain ATCC 11635 / DSM 40517 / JCM 4748 / NBRC 13426 / NCIMB 8594 / NRRL 2338) eryC1 gene Proteins 0.000 description 1
- 101100501742 Saccharopolyspora erythraea (strain ATCC 11635 / DSM 40517 / JCM 4748 / NBRC 13426 / NCIMB 8594 / NRRL 2338) eryK gene Proteins 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- NSFFHOGKXHRQEW-UHFFFAOYSA-N Thiostrepton B Natural products N1C(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC(=O)C(C(C)CC)NC(C(C2=N3)O)C=CC2=C(C(C)O)C=C3C(=O)OC(C)C(C=2SC=C(N=2)C2N=3)NC(=O)C(N=4)=CSC=4C(C(C)(O)C(C)O)NC(=O)C(N=4)CSC=4C(=CC)NC(=O)C(C(C)O)NC(=O)C(N=4)=CSC=4C21CCC=3C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 101150044616 araC gene Proteins 0.000 description 1
- 101150005693 arsR gene Proteins 0.000 description 1
- 101150112361 asnC gene Proteins 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960002626 clarithromycin Drugs 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- 101150106284 deoR gene Proteins 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 101150065098 glnG gene Proteins 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 101150094642 gntR gene Proteins 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 101150109249 lacI gene Proteins 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 101150016512 luxR gene Proteins 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 101150114554 marR gene Proteins 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 101150012415 ntrC gene Proteins 0.000 description 1
- 101150091444 ompR gene Proteins 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229930001119 polyketide Natural products 0.000 description 1
- 150000003881 polyketide derivatives Chemical class 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000019525 primary metabolic process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960005224 roxithromycin Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229960003250 telithromycin Drugs 0.000 description 1
- LJVAJPDWBABPEJ-PNUFFHFMSA-N telithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@@H]([C@]2(OC(=O)N(CCCCN3C=C(N=C3)C=3C=NC=CC=3)[C@@H]2[C@@H](C)C(=O)[C@H](C)C[C@@]1(C)OC)C)CC)[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O LJVAJPDWBABPEJ-PNUFFHFMSA-N 0.000 description 1
- 101150061166 tetR gene Proteins 0.000 description 1
- 229930188070 thiostrepton Natural products 0.000 description 1
- 229940063214 thiostrepton Drugs 0.000 description 1
- NSFFHOGKXHRQEW-AIHSUZKVSA-N thiostrepton Chemical compound C([C@]12C=3SC=C(N=3)C(=O)N[C@H](C(=O)NC(/C=3SC[C@@H](N=3)C(=O)N[C@H](C=3SC=C(N=3)C(=O)N[C@H](C=3SC=C(N=3)[C@H]1N=1)[C@@H](C)OC(=O)C3=CC(=C4C=C[C@H]([C@@H](C4=N3)O)N[C@H](C(N[C@@H](C)C(=O)NC(=C)C(=O)N[C@@H](C)C(=O)N2)=O)[C@@H](C)CC)[C@H](C)O)[C@](C)(O)[C@@H](C)O)=C\C)[C@@H](C)O)CC=1C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-AIHSUZKVSA-N 0.000 description 1
- NSFFHOGKXHRQEW-OFMUQYBVSA-N thiostrepton A Natural products CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]4NC(=O)c5csc(n5)[C@@H](NC(=O)[C@H]6CSC(=N6)C(=CC)NC(=O)[C@@H](NC(=O)c7csc(n7)[C@]8(CCC(=N[C@@H]8c9csc4n9)c%10nc(cs%10)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)[C@](C)(O)[C@@H](C)O)[C@H](C)O NSFFHOGKXHRQEW-OFMUQYBVSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 101150075472 ycf27 gene Proteins 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Abstract
The invention relates to the technical field of genetic engineering, and provides a method for improving erythromycin yield by modifying a Sace_5680 gene of rhodosporidium, wherein the GntR family SACE_5680 gene in rhodosporidium is deleted by a genetic engineering method, so that a high-yield engineering strain of erythromyces saccharopolyspora erythromycin is obtained, and the obtained high-yield engineering strain of erythromyces saccharopolyspora is used for fermenting and producing erythromycin; wherein the nucleotide sequence of the SACE_5680 gene is shown as SEQ ID NO. 1. The invention also provides an application of the method. The invention screens the erythromycin biosynthesis negative regulator SACE_5680, and the SACE_5680 gene copy on the chromosome of the rhodosporidium is deleted by a genetic engineering way, so that the erythromycin high-yield strain can be obtained, and the technical support is provided for improving the erythromycin fermentation yield in industrial production.
Description
Technical Field
The invention relates to the technical field of genetic engineering, in particular to a method for improving erythromycin yield by modifying rhodosporidium saccharum SACE_5680 gene and application thereof.
Background
Erythromycin is produced by the secondary metabolism of erythromyces saccharopolyspora, belongs to typical polyketide antibiotics, and comprises the components of erythromycin A (Er-A), erythromycin B (Er-B), erythromycin C (Er-C), erythromycin D (Er-D), erythromycin E (Er-E), erythromycin F (Er-F) and the like. The antibiotics have broad-spectrum antibacterial effect, the antibacterial spectrum of the antibiotics is similar to that of penicillin, and the antibiotics have strong inhibition effect on gram-positive bacteria. Erythromycin A is widely used clinically in the components of erythromycin, and has the highest antibacterial activity, and erythromycin series chemical derivatives (clarithromycin, azithromycin, roxithromycin, telithromycin and the like) are widely used for treating infectious diseases, and the selling amount of erythromycin and derivatives thereof is hundreds of billions of dollars each year.
Erythromycin has an important role in the pharmaceutical field, but its yield is still to be improved. The traditional method for improving the yield of erythromycin A by optimizing the fermentation conditions is time-consuming and uneconomical, and is not suitable for wide application. The erythromycin high-yield strain is obtained by increasing the copy number of the synthetic gene in the rhodosporidium saccharopolyspora chromosome by a genetic engineering method or modifying the regulatory gene by a gene knockout method, and has good prospect.
Ramos et al split the prokaryotic transcriptional regulator into 16 families of LysR, araC/XylS, tetR, luxR, lacI, arsR, icIR, merR, asnC, marR, ntrC (EBP), ompR, deoR, cold stock, gntR and crp based on sequence similarity, structure and function. GntR family transcription regulators are the most widely distributed class of helix-turn-helix (HTH) transcription regulators in bacteria, which contain two functional domains, an N-terminal DNA binding domain and a C-terminal effector binding/oligomerization domain, respectively. The amino acid sequence of the DNA domain is very conserved among GntR family members, but there is a great deal of variability in the amino acid sequence of the effector binding domain/oligomerization domain. Many transcription regulators of the GntR family have been identified, which regulate many different cellular processes of bacteria, such as motility, glucose metabolism, bacterial resistance, pathogenicity of pathogenic bacteria, etc. However, there is little research on the GntR family regulatory genes for the secondary metabolism of rhodosporidium saccharopolyspora.
Disclosure of Invention
The invention aims to provide a method for improving erythromycin yield by modifying rhodosporidium saccharopolyspora SACE_5680 gene and application thereof.
The invention adopts the following technical scheme to solve the technical problems:
A method for improving erythromycin yield by modifying Sace_5680 gene of rhodosporidium, deleting GntR family Sace_5680 gene in rhodosporidium by a genetic engineering method, obtaining a rhodosporidium erythromycin high-yield engineering strain, and fermenting and producing erythromycin by utilizing the obtained rhodosporidium erythromycin high-yield engineering strain; wherein the nucleotide sequence of the SACE_5680 gene is shown as SEQ ID NO. 1.
As one of the preferable modes of the invention, the amino acid sequence coded by the SACE_5680 gene is shown as SEQ ID NO. 2.
As one of the preferred modes of the invention, the SACE 5680 gene product negatively regulates erythromycin biosynthesis.
The application of the method for improving the erythromycin yield by modifying the rhodosporidium saccharum SACE_5680 gene is that the SACE_5680 gene is knocked out in an industrial high-yield strain to obtain a high-yield mutant strain which is used for erythromycin production.
As one of the preferred modes of the invention, the industrial high-yield strain specifically selects the rhodosporidium saccharopolyspora industrial strain WB, and correspondingly, the high-yield mutant strain is a WB-delta SACE_5680 strain.
Compared with the prior art, the invention has the advantages that:
The invention screens the erythromycin biosynthesis negative regulator SACE_5680, and the SACE_5680 gene copy on the chromosome of the rhodosporidium is deleted by a genetic engineering way, so that the erythromycin high-yield strain can be obtained, and the technical support is provided for improving the erythromycin fermentation yield in industrial production. Wherein, when SACE_5680 gene is knocked out in rhodosporidium saccharum A226, erythromycin yield is increased by 22%, and SACE_5680 gene is supplemented back in delta SACE_5680 deletion mutant, erythromycin yield is recovered, which indicates that SACE_5680 is a negative regulatory factor involved in erythromycin biosynthesis. In addition, by using industrial high-yield strain WB as the starting strain, the SACE_5680 gene was deleted on its chromosome to increase erythromycin yield by 53%, and the technique of deleting SACE_5680 gene to increase erythromycin yield was also applicable to industrial high-yield strain.
Drawings
FIG. 1 is a diagram showing the positional information of SACE_5680 gene and peripheral adjacent genes on a chromosome;
FIG. 2 is a schematic diagram of the construction of a ΔSACE_5680 mutant;
FIG. 3 is a PCR identification chart of a ΔSACE_5680 mutant strain (in the figure, SACE_5680 gene is not knocked out, 666bp; SACE_5680 gene is knocked out, 360bp;M,5000bp DNA Marker);
FIG. 4 is a diagram of PCR identification of ΔSACE_5680/pIB139-5680 complementation strain (in the figure, PCR product is apramycin resistance gene, 776bp;M,5000bp DNAMarker);
fig. 5 is an analysis of erythromycin a production by starting strain a226 and deletion mutant Δsace_5680 (in the figure, "x" indicates that there is a significant difference, p < 0.001);
fig. 6 is an HPLC analysis of erythromycin a for the starting strain a226, deletion mutant Δsace_5680, deletion complement strain Δsace_5680/pIB139-5680, and complement empty control strain Δsace_5680/pIB139 (in the figure, "x" indicates that there is a significant difference, p < 0.001).
FIG. 7 is a graph of the biological measurement results of mycelia of the ΔSACE_5680 mutant strain and the wild type A226 strain;
Fig. 8 shows the transcription level of erythromycin synthesis gene cluster-related gene in Δsace_5680 (in the figure, "+" indicates p <0.01, "+" indicates p < 0.001);
fig. 9 is an HPLC analysis of the yield of erythromycin a from high yielding strain WB/Δsace_5680 (in the figure, "×" indicates that there is a significant difference, p < 0.01).
Detailed Description
The following describes in detail the examples of the present invention, which are implemented on the premise of the technical solution of the present invention, and detailed embodiments and specific operation procedures are given, but the scope of protection of the present invention is not limited to the following examples.
The strains and plasmids used in the examples below are shown in Table 1, and the primer sequences synthesized are shown in Table 2. Wherein the original strain is rhodosporidium saccharopolyspora A226 (CGMCC 8279) which can be directly purchased.
Meanwhile, E.coli used in the following examples was cultured on a liquid LB medium at 37℃or on a solid LB plate with 1.25% agar added. Erythromyces and its engineering strains were cultured in Tryptone Soy Broth (TSB) medium at 30 ℃ or on R3M plates containing 2.2% agar.
Among the materials used in the examples below, PEG3350, lysozyme, TES, casamino acid, thiostrepton, and apramycin were purchased from Sigma. TSB, yeast extract, peptone were purchased from Oxoid corporation. Glycine, agar powder, sodium chloride and other biological agents are all purchased from reagent companies. General procedures for E.coli and Rhodotorula saccharopolyspora are standard procedures. Primer synthesis and DNA sequencing were performed by biological engineering (Shanghai) Inc.
TABLE 1 bacterial species, plasmids and their main properties according to the invention
TABLE 2 primers according to the invention
Example 1
Analysis of SACE_5680 gene:
The locations of SACE_5680 and adjacent genes on the chromosome of Rhodosporidium saccharopolyspora are shown in FIG. 1.
The nucleotide sequence of the SACE_5680 gene is shown as SEQ ID NO.1, the gene length is 666bp, the encoded amino acid sequence is shown as SEQ ID NO.2, and the protein monomer size is 24.4kDa.
Example 2
Construction of SACE_5680 Gene deletion mutant (see FIG. 2):
The genome DNA of rhodosporidium saccharopolyspora A226 is used as a template, primers 5680UF/5680UR and 5680DF/5680DR are used for PCR amplification to obtain upstream and downstream homology arms of 1.5kb, and HindIII, xba I, ecoR I and Xba I are used for digestion and recovery; simultaneously, the vector pKC1139 is cut out by HindIII and EcoRI enzymes and recovered; the recovered upstream and downstream homology arms and pKC1139 plasmid are connected and transformed and then transferred into DH5 alpha, and the pKC 1139-delta 5680 is obtained through PCR and enzyme digestion identification.
Transferring the constructed plasmid pKC 1139-delta 5680 into the prepared rhodosporidium saccharopolyspora A226 protoplast, coating the protoplast on an R3M solid plate without resistance (placing the plate in a baking oven at 37 ℃ for 48 hours after drying the plate), placing the plate in a constant temperature incubator at 30 ℃ for culturing for about 20 hours, adding aseptic water of apramycin (Apr) to cover the plate (the final concentration is 50 mug/mL apramycin), and culturing for 4-5 days at 30 ℃ continuously until monoclonal grows. The grown monoclonal is transferred to an R3M solid plate containing 50 mug/mL apramycin for enrichment, and spores grow out after culturing for 4-5 days at 30 ℃. And (3) a small amount of spores are taken and scratched in an R3M solid flat plate without resistance, and then the spores are placed in a constant temperature incubator at 37 ℃ for 2-3 d to finish the relaxation and loss of plasmids. When the monoclonal grows out from the plate, half of the monospore is selected in the R3M solid plate without the antibody, and the other half of the monospore is selected in the R3M solid plate containing 50 mug/mL apramycin, and is cultured for 4-5 d at 30 ℃. Bacterial strains growing in R3M solid plates without apramycin are scraped with a small amount of spores for bacterial liquid PCR, the identified primers are 5680JDF and 5680JDR, the positive control template is pKC 1139-delta 5680 plasmid, the negative control template is A226 genome, and the delta SACE_5680 deletion mutant is obtained according to the size of PCR products (see figure 3).
Example 3
Construction of SACE_5680 Gene complementation and overexpression Strain:
The SACE_5680 gene was amplified using the designed primers 5680-P1 and 5680-P2, and electrophoretically recovered, and the recovered SACE_5680 gene fragment and pIB139 were digested with Nde I and Xba I endonucleases, respectively, and the SACE_5680 gene fragment was ligated to pIB139 by T4 DNA ligase to successfully obtain the integrative plasmid pIB139-5680. The pIB139-5680 was then introduced into ΔSACE_5680 protoplasts by PEG-mediated protoplast transformation. By preliminary screening of apramycin, PCR identification was performed with the apramycin resistance gene as a target, and as shown in FIG. 4, the recovered strain was named ΔSACE_5680/pIB139-5680.
Example 4
HPLC detection of rhodosporidium saccharopolyspora fermentation product:
Inoculating rhodosporidium to TSB culture medium, shake culturing at 30deg.C for 48 hr, transferring to R5 liquid culture medium, shake culturing at 30deg.C for 168 hr, extracting fermentation liquid with organic solvent, evaporating to dryness in water bath, adding 1mL methanol for dissolving, treating with 0.22 μm organic filter membrane, and detecting erythromycin A content in sample.
Example 5
Detecting the biomass of rhodosporidium saccharopolyspora mycelium:
The delta SACE_5680 mutant and A226 are respectively inoculated into 30mL of liquid TSB with the same inoculum size, shake-cultured for 48 hours at 30 ℃, then transferred into an R5 culture medium, shake-cultured for 168 hours at the rotational speed of 220rpm at 30 ℃, sampled in different time periods, washed by absolute ethyl alcohol, dried and weighed to obtain the dry weight of the thalli, and after measurement, a biomass curve of the thalli is drawn according to experimental data.
Example 6
Transcriptional analysis of genes within the erythromycin biosynthesis gene cluster in Δsace_5680:
To investigate the level of transcription of genes associated with the erythromycin synthesis gene cluster in the ΔSACE_5680 strain, an RT-qRCR experiment was performed (see Table 2 for relevant primers). And (3) fermenting the delta SACE_5680 and the A226 in an R5 culture medium for 24 hours, taking 1mL of fermentation liquid in a homogenizing tube, centrifuging at 4 ℃ and 12000rpm for 15 minutes, removing the supernatant, adding a 1mL Transzol reagent, homogenizing, vibrating and crushing, extracting total RNA by using an RNA extraction kit, quantifying the Nanodrop, and selecting RNA with the OD260/280 of 1.9-2.2 for subsequent experimental operation. Digesting genomic DNA in RNA, then reversely transcribing the genomic DNA into cDNA in time, finally preparing a reaction system by using the reverse transcribed cDNA as a template and using an RT-qPCR kit, and detecting the transcription level of genes related to erythromycin synthesis gene clusters on a qPCR instrument.
Example 7
Construction of erythromycin industrial high-yield strain WB/delta SACE_5680 strain and HPLC detection:
SACE_5680 was deleted in the erythromycin industrial high-producing strain WB, and the correct strain was verified to be named WB/ΔSACE_5680. And HPLC detection is carried out on fermentation products of the WB high-yield strain and the deletion mutant strain WB/deltaSACE_5680. Mutant construction procedures and HPLC detection are referred to above in the examples.
Example 8
Specific experimental results of the above examples:
1. Deletion mutant ΔSACE_5680 showed increased erythromycin production compared with starting strain A226.
After ΔSACE_5680 was fermented in the fermentation medium for 7d, the yield of erythromycin A was checked by HPLC, and ΔSACE_5680 was found to be 22% higher than that of starting strain A226 (see FIG. 5), and HPLC results indicated that SACE_5680 was a negative regulator involved in erythromycin biosynthesis.
2. The SACE_5680 gene reverts to and overexpresses.
To verify that the increase in erythromycin production in mutant ΔSACE_5680 was due to a SACE_5680 gene deletion, SACE_5680 gene expression vectors pIB139-5680 and pIB139 vectors (as controls) were introduced into protoplasts of the ΔSACE_5680 mutant strain to obtain revertant and empty ΔSACE_5680/pIB139-5680, ΔSACE_5680/pIB139. After PCR identification, A226 and delta SACE_5680 series mutant strains are subjected to shake flask fermentation, and HPLC detection results show that: erythromycin A yield of ΔSACE_5680 was 22% higher than A226; the erythromycin A production of the revertant strain ΔSACE_5680/pIB139-5680 was substantially recovered compared to A226 (see FIG. 6); HPLC detection further indicates that SACE_5680 gene can down regulate erythromycin A biosynthesis.
3. Influence of deletion of SACE_5680 gene on cell growth.
The Δsace_5680 mutant and the strain a226 strain were subjected to fermentation for 7 days, and the dry weight of the cells was plotted to give a corresponding change curve, which showed that Δsace_5680 was not significantly different from the biomass of strain a226 (see fig. 7), suggesting that the deletion of the sace_5680 gene did not affect the primary metabolism of the cells.
4. The Δsace_5680 mutant has increased transcription of genes within the erythromycin biosynthesis gene cluster.
Transcript levels of ermE, eryAI, eryCI, eryK, eryBI, eryBIII, eryBIV and eryBVI were both significantly increased in the Δsace_5680 mutant compared to the starting strain A226. It was demonstrated that SACE_5680 had a direct regulatory effect on transcription of genes within the erythromycin biosynthesis gene cluster (see FIG. 8).
5. The engineered industrial high-yielding strain WB/ΔSACE_5680 resulted in increased erythromycin production.
After constructing the WB/delta SACE_5680 mutant, activating the WB/delta SACE_5680 mutant and the industrial high-yield strain WB by coating plates, respectively inoculating into shake flasks of an industrial seed culture medium, culturing for 2 days at the rotating speed of 220rpm at 30 ℃, transferring into an industrial fermentation culture medium, and continuously culturing for 7 days. After fermentation, the extraction concentration is analyzed by HPLC, and compared with the starting strain WB, the erythromycin yield of WB/delta SACE_5680 is improved by 53 percent (see figure 9). This suggests that the SACE_5680 gene in the high producing strain WB is also involved in regulating erythromycin production.
The foregoing description of the preferred embodiments of the invention is not intended to be limiting, but rather is intended to cover all modifications, equivalents, and alternatives falling within the spirit and principles of the invention.
Claims (5)
1. A method for improving the yield of erythromycin by modifying the SACE_5680 gene of rhodosporidium is characterized in that the GntR family SACE_5680 gene in rhodosporidium is deleted by a genetic engineering method, so that a high-yield engineering strain of rhodosporidium erythromycin is obtained, and the obtained high-yield engineering strain of rhodosporidium erythromycin is used for fermenting and producing erythromycin; wherein the nucleotide sequence of the SACE_5680 gene is shown as SEQ ID NO. 1.
2. The method for improving erythromycin yield by modifying the SACE 5680 gene of rhodosporidium saccharopolyspora according to claim 1, wherein the amino acid sequence encoded by the SACE 5680 gene is shown in SEQ ID No. 2.
3. The method for increasing erythromycin yield by engineering a rhodosporidium saccharum SACE 5680 gene according to claim 1 wherein said SACE 5680 gene product negatively regulates erythromycin biosynthesis.
4. Use of a method for increasing the yield of erythromycin by engineering the SACE 5680 gene of rhodosporidium saccharopolyspora as claimed in any of claims 1 to 3, characterized in that the SACE 5680 gene is knocked out in an industrial high-yielding strain, obtaining a high-yielding mutant strain for the production of erythromycin.
5. The use of the method for increasing erythromycin yield by engineering a rhodosporidium SACE 5680 gene according to claim 4, characterized in that said industrial high-yielding strain is specifically selected from rhodosporidium industrial strain WB, correspondingly said high-yielding mutant strain is WB- Δsace 5680 strain.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410109259.3A CN117904162A (en) | 2024-01-25 | 2024-01-25 | Method for improving erythromycin yield by modifying rhodosporidium saccharatum SACE_5680 gene and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410109259.3A CN117904162A (en) | 2024-01-25 | 2024-01-25 | Method for improving erythromycin yield by modifying rhodosporidium saccharatum SACE_5680 gene and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117904162A true CN117904162A (en) | 2024-04-19 |
Family
ID=90697370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410109259.3A Pending CN117904162A (en) | 2024-01-25 | 2024-01-25 | Method for improving erythromycin yield by modifying rhodosporidium saccharatum SACE_5680 gene and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117904162A (en) |
-
2024
- 2024-01-25 CN CN202410109259.3A patent/CN117904162A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106520866B (en) | Method for improving yield of erythromycin by modifying saccharopolyspora erythraea SACE _3980 gene | |
CN110157756B (en) | Method for improving erythromycin yield by modifying saccharopolyspora erythraea SACE _0303 gene | |
CN107881190B (en) | Method for improving lincomycin yield by modifying streptomyces lincolnensis SLCG _2919 gene | |
CN103849642A (en) | Method for improving yield of erythromycin through saccharopolyspora erythraea SACE _3986 gene | |
CN114410560B (en) | Engineering strain for high-yield FK228 and construction and application thereof | |
CN112251456B (en) | Method for improving lincomycin yield through streptomyces lincolnensis regulation gene combination modification | |
CN109136253B (en) | Method for improving yield of erythromycin through saccharopolyspora erythraea SACE _5754 gene approach | |
CN112899210B (en) | Method for improving validamycin fermentation level by enhancing positive regulatory protein gene expression | |
CN109321618B (en) | Method for improving erythromycin yield through saccharopolyspora erythraea SACE _5717 gene | |
CN110484481B (en) | Method for improving lincomycin yield by modifying streptomyces lincolnensis SLCG _3128 gene | |
CN111139192B (en) | Method for improving erythromycin yield by modifying saccharopolyspora erythraea SACE _4682 gene | |
CN117904162A (en) | Method for improving erythromycin yield by modifying rhodosporidium saccharatum SACE_5680 gene and application | |
CN111197019B (en) | Method for improving yield of erythromycin through saccharopolyspora erythraea SACE _1906 gene approach | |
CN111363710B (en) | Method for improving yield of erythromycin through saccharopolyspora erythraea SACE _4839 gene pathway | |
CN106148378A (en) | Improve yield of erythrocin by sugared many spores red mould SACE_Lrp gene approach | |
CN102373171B (en) | Nucleoside antibiotic A201A superior strain and construction method thereof | |
CN117568301B (en) | Method for improving erythromycin yield through rhodosporidium saccharum SACE-1646 gene | |
CN113755517B (en) | Construction method and application of SLCG _5407 gene modified streptomyces lincolnensis | |
CN112795587A (en) | Escherichia coli engineering bacterium for producing surfactin and construction method and application thereof | |
CN114457101B (en) | Method for improving erythromycin yield by modifying rhodosporidium saccharatum SACE_1558 gene and application | |
CN115433685B (en) | Method for improving yield of erythromycin by modifying saccharopolyspora erythraea SACE _5812 gene | |
CN114806992B (en) | RSH over-expression genetic engineering amylase streptomyces chromogenes and method for improving fermentation yield of toyocamycin | |
CN116445515B (en) | Gene cluster participating in Li Pusi statin and structural analogue synthesis and application thereof | |
CN117660279B (en) | Method for improving thaxtomin A yield through streptomyces scab SCAB _75421 gene | |
CN114150006B (en) | Gene cluster and recombinant bacterium capable of improving milbemycins yield and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |